In the tumor necrosis factor (TNF)-NF-κB axis, inhibition of NF-κB signaling by anti-TNF-α agents or activation of the repressor IkB to control inflammation also inhibits the progression of HCC [113]. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.